Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2008CirculationOpen Access

Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRichard J. PowellDartmouth College
Michael Simons
Michael SimonsVascular / Pulmonary VascularFMFarrel O. MendelsohnDuke University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Powell et al. (2008) studied this question.

synapsesocial.com/papers/69d42b9aba6088fd29e109a2https://doi.org/10.1161/circulationaha.107.727347
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.1994 · 1,046 citations
  2. 2Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease2004 · 239 citations
  3. 3Improvement in Chronic Ischemic Neuropathy After Intramuscular phVEGF165 Gene Transfer in Patients With Critical Limb Ischemia2001 · 118 citations
  4. 4Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy1999 · 270 citations